Search
Patexia Research
Case number 3:25-cv-00231

ASTRAZENECA PHARMACEUTICALS LP et al v. SANDOZ INC. > Documents

Date Field Doc. No.Description (Pages)
Jun 6, 2025 16 LETTER ORDER that the Court finds that the new lawsuits shall be consolidated with 23-cv-796. The Court further finds that the parties' shall disclose their contentions in the standard order outlined in L.Pat.R. 3.6 according to the enclosed schedule. Cases associated. Signed by Magistrate Judge Tonianne J. Bongiovanni on 6/6/2025. (mlh) (Entered: 06/06/2025) (2)
Jun 6, 2025 N/A ***Civil Case Terminated. (mlh) (Entered: 06/06/2025) (0)
Apr 15, 2025 15 ANSWER to Counterclaim by ASTRAZENECA AB, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED, KUDOS PHARMACEUTICALS LIMITED, MSD INTERNATIONAL BUSINESS GMBH.(CHEVALIER, CHARLES) (Entered: 04/15/2025) (16)
Mar 13, 2025 14 Application and Proposed Order for Clerk's Order to extend time to answer. (CHEVALIER, CHARLES) (Entered: 03/13/2025) (2)
Mar 13, 2025 N/A Clerk`s Text Order - The document 14 Application for Clerk's Order to Ext Answer/Proposed Order submitted by ASTRAZENECA AB, ASTRAZENECA UK LIMITED, ASTRAZENECA PHARMACEUTICALS LP, KUDOS PHARMACEUTICALS LIMITED, and MSD INTERNATIONAL BUSINESS GMBH has been GRANTED. The answer due date has been set for 4/15/2025. (mlh) (Entered: 03/13/2025) (0)
Mar 11, 2025 10 NOTICE of Appearance by ERIC I. ABRAHAM on behalf of SANDOZ INC. (ABRAHAM, ERIC) (Entered: 03/11/2025) (2)
Mar 11, 2025 11 NOTICE of Appearance by KRISTINE L. BUTLER on behalf of SANDOZ INC. (BUTLER, KRISTINE) (Entered: 03/11/2025) (2)
Mar 11, 2025 12 Sandoz Inc.'s ANSWER to Complaint with JURY DEMAND , COUNTERCLAIM against All Plaintiffs by SANDOZ INC..(ABRAHAM, ERIC) (Entered: 03/11/2025) (30)
Mar 11, 2025 13 Corporate Disclosure Statement by SANDOZ INC. identifying Sandoz AG as Corporate Parent.. (ABRAHAM, ERIC) (Entered: 03/11/2025) (4)
Jan 15, 2025 9 WAIVER OF SERVICE Returned Executed by KUDOS PHARMACEUTICALS LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED, MSD INTERNATIONAL BUSINESS GMBH. SANDOZ INC. waiver sent on 1/10/2025, answer due 3/11/2025. (CHEVALIER, CHARLES) (Entered: 01/15/2025) (1)
Jan 10, 2025 7 AO120 Patent/Trademark Form filed. (dmr3) (Entered: 01/10/2025) (1)
Jan 10, 2025 8 SUMMONS ISSUED as to SANDOZ INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (dmr3) (Entered: 01/10/2025) (2)
Jan 9, 2025 1 Complaint* (1)
Jan 9, 2025 2 Corporate Disclosure Statement by ASTRAZENECA PHARMACEUTICALS LP identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025) (2)
Jan 9, 2025 3 Corporate Disclosure Statement by ASTRAZENECA UK LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025) (2)
Jan 9, 2025 4 Corporate Disclosure Statement by ASTRAZENECA AB identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025) (2)
Jan 9, 2025 5 Corporate Disclosure Statement by KUDOS PHARMACEUTICALS LIMITED identifying AstraZeneca PLC as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025) (2)
Jan 9, 2025 6 Corporate Disclosure Statement by MSD INTERNATIONAL BUSINESS GMBH identifying Merck & Co., Inc. as Corporate Parent.. (CHEVALIER, CHARLES) (Entered: 01/09/2025) (2)
Jan 9, 2025 N/A Judge Robert Kirsch and Magistrate Judge Tonianne J. Bongiovanni added. (dmr3) (Entered: 01/10/2025) (0)
Menu